501 F.Supp.2d 776 (E.D.La. 2007), MDL 1657, In re Vioxx Products Liability Litigation

Citation: 501 F.Supp.2d 776

Party Name: In re: VIOXX PRODUCTS LIABILITY LITIGATION This Document Relates to: Arnold v. Merck & Co., Inc., No. 05-2627. Gomez v. Merck & Co., Inc., No. 05-1163.

Case Date: July 03, 2007

Court: U.S. District Court — Eastern District of Louisiana

Linked as:

Document options

Printable page
Email this

Extract

501 F.Supp.2d 776 (E.D.La. 2007), MDL 1657, In re Vioxx Products Liability Litigation

No longer available (Autolink)

See the full content of this document

This document cites

Code of Federal Regulations - Requirements on content and format of labeling for human prescription drug and biological products
Code of Federal Regulations - Supplements and other changes to an approved NDA
Code of Federal Regulations - Approval of an NDA and an ANDA
US Code - 21 U.S.C. § 16 Introduction Into, Or Sale In, State Or Territory Or District of Columbia of Dairy Or Food Products Falsely Labeled Or Branded
US Code - 21 U.S.C. § 301 Short Title

See all quotations